Photo of Ashley M. Holder

View Scopus Profile

Ashley M. Holder, MD

Former affiliations
  • 633 Citations
  • 10 h-Index
20072020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Area Keywords

  • Clinical Care
  • Clinical Translation & Trials
  • Nanomedicine

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 633 Citations
  • 10 h-Index
  • 12 Article
  • 2 Chapter
  • 2 Review article
  • 1 Comment/debate

Integration of Digital Pathologic and Transcriptomic Analyses Connects Tumor-Infiltrating Lymphocyte Spatial Density With Clinical Response to BRAF Inhibitors

Ziemys, A., Kim, M., Menzies, A. M., Wilmott, J. S., Long, G. V., Scolyer, R. A., Kwong, L., Holder, A. M. & Boland, G., May 14 2020, In : Frontiers in Oncology. 10, 757.

Research output: Contribution to journal › Article

    • Cancer of unknown primary site

    Holder, A. M. & Varadhachary, G. R., Jan 1 2018, The MD Anderson Surgical Oncology Handbook, Sixth Edition. Wolters Kluwer Health Adis (ESP), p. 613-626 14 p.

    Research output: Chapter in Book/Report/Conference proceeding › Chapter

    Chemotherapy sensitizes therapy-resistant cells to mild hyperthermia by suppressing heat shock protein 27 expression in triple-negative breast cancer

    Mu, C., Wu, X., Zhou, X., Wolfram, J., Shen, J., Zhang, D., Mai, J., Xia, X., Holder, A. M., Ferrari, M., Liu, X. & Shen, H., Oct 1 2018, In : Clinical Cancer Research. 24, 19, p. 4900-4912 13 p.

    Research output: Contribution to journal › Article

    • 8 Scopus citations

    Progression-dependent transport heterogeneity of breast cancer liver metastases as a factor in therapeutic resistance

    Ziemys, A., Yokoi, K., Kai, M., Liu, Y. T., Kojic, M., Simic, V., Milosevic, M., Holder, A. M. & Ferrari, M., Dec 10 2018, In : Journal of Controlled Release. 291, p. 99-105 7 p.

    Research output: Contribution to journal › Article

    • 5 Scopus citations

    Erratum: Ability to generate patient-derived breast cancer xenografts is enhanced in chemoresistant disease and predicts poor patient outcomes (PLoS ONE (2015) 10:9 (e0136851) DOI: 10.1371/journal.pone.0136851)

    McAuliffe, P. F., Evans, K. W., Akcakanat, A., Chen, K., Zheng, X., Zhao, H., Eterovic, A. K., Sangai, T., Holder, A. M., Sharma, C., Chen, H., Do, K. A., Tarco, E., Gagea, M., Naff, K. A., Sahin, A., Multani, A. S., Black, D. M., Mittendorf, E. A., Bedrosian, I. & 3 others, Mills, G. B., Gonzalez-Angulo, A. M. & Meric-Bernstam, F., Mar 2016, In : PLoS ONE. 11, 3, e0151121.

    Research output: Contribution to journal › Comment/debate

    1 Scopus citations